These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 36857175
1. Interferon regulatory factor 1 (IRF1) inhibits lung endothelial regeneration following inflammation-induced acute lung injury. Chen X, Qi D, Fan S, He Y, Jing H, Wang D. Clin Sci (Lond); 2023 Mar 15; 137(5):367-383. PubMed ID: 36857175 [Abstract] [Full Text] [Related]
2. IFIH1/IRF1/STAT1 promotes sepsis associated inflammatory lung injury via activating macrophage M1 polarization. Wang A, Kang X, Wang J, Zhang S. Int Immunopharmacol; 2023 Jan 15; 114():109478. PubMed ID: 36462334 [Abstract] [Full Text] [Related]
3. PLD2 deficiency alleviates endothelial glycocalyx degradation in LPS-induced ARDS/ALI. Kong G, Li D, Liu X, Feng J, Ning F, Huang X, Qi B, Qu J, Wang X. Biochem Biophys Res Commun; 2024 Jul 05; 716():150019. PubMed ID: 38703555 [Abstract] [Full Text] [Related]
4. PLD2 deletion alleviates disruption of tight junctions in sepsis-induced ALI by regulating PA/STAT3 phosphorylation pathway. Qian T, Qi B, Fei Y, Li J, Luo L, Lv B, Song Y, Sheng S, Xiao W, Huang X, Wang X. Int Immunopharmacol; 2023 Jan 05; 114():109561. PubMed ID: 36700766 [Abstract] [Full Text] [Related]
5. The myosin II inhibitor, blebbistatin, ameliorates pulmonary endothelial barrier dysfunction in acute lung injury induced by LPS via NMMHC IIA/Wnt5a/β-catenin pathway. Zhang J, Pan Z, Zhou J, Zhang L, Tang J, Gong S, Li F, Yu B, Zhang Y, Kou J. Toxicol Appl Pharmacol; 2022 Sep 01; 450():116132. PubMed ID: 35716767 [Abstract] [Full Text] [Related]
6. The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation and puncture (CLP) in mice. Yang L, Liu S, Han S, Hu Y, Wu Z, Shi X, Pang B, Ma Y, Jin J. Respir Res; 2020 Nov 04; 21(1):293. PubMed ID: 33148285 [Abstract] [Full Text] [Related]
7. Inhibition of fatty acid synthase protects obese mice from acute lung injury via ameliorating lung endothelial dysfunction. Wu Z, Zhu L, Nie X, Liu Y, Zhang X, Qi Y. Respir Res; 2023 Mar 15; 24(1):81. PubMed ID: 36922854 [Abstract] [Full Text] [Related]
8. Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury. Lee EH, Shin MH, Gi M, Park J, Song D, Hyun YM, Ryu JH, Seong JK, Jeon Y, Han G, Namkung W, Park MS, Choi JY. Theranostics; 2020 Mar 15; 10(22):9913-9922. PubMed ID: 32929324 [Abstract] [Full Text] [Related]
9. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. Gonzales JN, Gorshkov B, Varn MN, Zemskova MA, Zemskov EA, Sridhar S, Lucas R, Verin AD. Am J Physiol Lung Cell Mol Physiol; 2014 Mar 15; 306(6):L497-507. PubMed ID: 24414256 [Abstract] [Full Text] [Related]
16. Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia. Wang L, Cao Y, Gorshkov B, Zhou Y, Yang Q, Xu J, Ma Q, Zhang X, Wang J, Mao X, Zeng X, Su Y, Verin AD, Hong M, Liu Z, Huo Y. Pharmacol Res; 2019 Aug 15; 146():104292. PubMed ID: 31167111 [Abstract] [Full Text] [Related]
17. Geranylgeranyl diphosphate synthase deficiency hyperactivates macrophages and aggravates lipopolysaccharide-induced acute lung injury. Jin J, Qian H, Wan B, Zhou L, Chen C, Lv Y, Chen M, Zhu S, Ye L, Wang X, Xu W, Lv T, Song Y. Am J Physiol Lung Cell Mol Physiol; 2021 Jun 01; 320(6):L1011-L1024. PubMed ID: 33729030 [Abstract] [Full Text] [Related]